
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗
Paolo Mulatero, Silvia Monticone, Jaap Deinum, et al.
Journal of Hypertension (2020) Vol. 38, Iss. 10, pp. 1919-1928
Open Access | Times Cited: 229
Paolo Mulatero, Silvia Monticone, Jaap Deinum, et al.
Journal of Hypertension (2020) Vol. 38, Iss. 10, pp. 1919-1928
Open Access | Times Cited: 229
Showing 1-25 of 229 citing articles:
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1600
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Faßnacht, Stylianos Tsagarakis, Massimo Terzolo, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 1, pp. G1-G42
Open Access | Times Cited: 276
Martin Faßnacht, Stylianos Tsagarakis, Massimo Terzolo, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 1, pp. G1-G42
Open Access | Times Cited: 276
Diagnosis and treatment of primary aldosteronism
Martín Reincke, Irina Bancos, Paolo Mulatero, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 12, pp. 876-892
Closed Access | Times Cited: 204
Martín Reincke, Irina Bancos, Paolo Mulatero, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 12, pp. 876-892
Closed Access | Times Cited: 204
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021
Mitsuhide Naruse, Takuyuki Katabami, Hirotaka Shibata, et al.
Endocrine Journal (2022) Vol. 69, Iss. 4, pp. 327-359
Open Access | Times Cited: 139
Mitsuhide Naruse, Takuyuki Katabami, Hirotaka Shibata, et al.
Endocrine Journal (2022) Vol. 69, Iss. 4, pp. 327-359
Open Access | Times Cited: 139
Aldosterone as a Mediator of Cardiovascular Damage
Fabrizio Buffolo, Martina Tetti, Paolo Mulatero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1899-1911
Open Access | Times Cited: 106
Fabrizio Buffolo, Martina Tetti, Paolo Mulatero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1899-1911
Open Access | Times Cited: 106
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 90
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 90
Screening for primary aldosteronism on and off interfering medications
Xiaoyu Li, Jiayu Liang, Jinbo Hu, et al.
Endocrine (2023) Vol. 83, Iss. 1, pp. 178-187
Open Access | Times Cited: 43
Xiaoyu Li, Jiayu Liang, Jinbo Hu, et al.
Endocrine (2023) Vol. 83, Iss. 1, pp. 178-187
Open Access | Times Cited: 43
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension
Gian Paolo Rossi, Valeria Bisogni, Giacomo Rossitto, et al.
High Blood Pressure & Cardiovascular Prevention (2020) Vol. 27, Iss. 6, pp. 547-560
Open Access | Times Cited: 106
Gian Paolo Rossi, Valeria Bisogni, Giacomo Rossitto, et al.
High Blood Pressure & Cardiovascular Prevention (2020) Vol. 27, Iss. 6, pp. 547-560
Open Access | Times Cited: 106
Genetics of Primary Aldosteronism
Ute I. Scholl
Hypertension (2022) Vol. 79, Iss. 5, pp. 887-897
Open Access | Times Cited: 65
Ute I. Scholl
Hypertension (2022) Vol. 79, Iss. 5, pp. 887-897
Open Access | Times Cited: 65
Primary Aldosteronism: State-of-the-Art Review
Anand Vaidya, Gregory L. Hundemer, Kazutaka Nanba, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 967-988
Open Access | Times Cited: 65
Anand Vaidya, Gregory L. Hundemer, Kazutaka Nanba, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 967-988
Open Access | Times Cited: 65
Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study
Parminder Singh Reel, Smarti Reel, Josie C. van Kralingen, et al.
EBioMedicine (2022) Vol. 84, pp. 104276-104276
Open Access | Times Cited: 49
Parminder Singh Reel, Smarti Reel, Josie C. van Kralingen, et al.
EBioMedicine (2022) Vol. 84, pp. 104276-104276
Open Access | Times Cited: 49
Primary Aldosteronism: Where Are We Now? Where to From Here?
John W. Funder, Robert M. Carey
Hypertension (2022) Vol. 79, Iss. 4, pp. 726-735
Open Access | Times Cited: 44
John W. Funder, Robert M. Carey
Hypertension (2022) Vol. 79, Iss. 4, pp. 726-735
Open Access | Times Cited: 44
The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism
Yanqing Zheng, Tingting Long, Ning Peng, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. 171-182
Open Access | Times Cited: 29
Yanqing Zheng, Tingting Long, Ning Peng, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. 171-182
Open Access | Times Cited: 29
The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study
Wasita Warachit Parksook, Jenifer M. Brown, Kei Omata, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. 2220-2232
Open Access | Times Cited: 16
Wasita Warachit Parksook, Jenifer M. Brown, Kei Omata, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. 2220-2232
Open Access | Times Cited: 16
Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy
Martina Tetti, Denise Brüdgam, Jacopo Burrello, et al.
Hypertension (2024) Vol. 81, Iss. 4, pp. 936-945
Closed Access | Times Cited: 13
Martina Tetti, Denise Brüdgam, Jacopo Burrello, et al.
Hypertension (2024) Vol. 81, Iss. 4, pp. 936-945
Closed Access | Times Cited: 13
Evaluation of a Best-Practice Advisory for Primary Aldosteronism Screening
Suranut Charoensri, Linda Bashaw, Cheryl Dehmlow, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 2, pp. 174-174
Closed Access | Times Cited: 12
Suranut Charoensri, Linda Bashaw, Cheryl Dehmlow, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 2, pp. 174-174
Closed Access | Times Cited: 12
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial
Paolo Mulatero, Grégoire Wuerzner, Michael Groessl, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102576-102576
Open Access | Times Cited: 11
Paolo Mulatero, Grégoire Wuerzner, Michael Groessl, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102576-102576
Open Access | Times Cited: 11
Advances in multimodal imaging for adrenal gland disorders: integrating CT, MRI, and nuclear medicine
Kota Yokoyama, Mitsuru Matsuki, Tetsuro Isozaki, et al.
Japanese Journal of Radiology (2025)
Open Access | Times Cited: 1
Kota Yokoyama, Mitsuru Matsuki, Tetsuro Isozaki, et al.
Japanese Journal of Radiology (2025)
Open Access | Times Cited: 1
Approach to Endocrine Hypertension: A Case-Based Discussion
Sanja Borozan, A B Kamrul-Hasan, Sahana Shetty, et al.
Current Hypertension Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Sanja Borozan, A B Kamrul-Hasan, Sahana Shetty, et al.
Current Hypertension Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Screening of primary aldosteronism and pheochromocytoma among patients with hypertension: an Italian nationwide survey
Silvia Monticone, Jessica Goi, Jacopo Burrello, et al.
Journal of Endocrinological Investigation (2025)
Open Access | Times Cited: 1
Silvia Monticone, Jessica Goi, Jacopo Burrello, et al.
Journal of Endocrinological Investigation (2025)
Open Access | Times Cited: 1
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
Daniel Gillett, Russell Senanayake, James MacFarlane, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268425-jnumed.124.268425
Closed Access | Times Cited: 1
Daniel Gillett, Russell Senanayake, James MacFarlane, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268425-jnumed.124.268425
Closed Access | Times Cited: 1
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy
Graeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 5, pp. e2027-e2036
Open Access | Times Cited: 51
Graeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 5, pp. e2027-e2036
Open Access | Times Cited: 51
Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
Adina F. Turcu, Winnie Nhan, Seda Grigoryan, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 14
Open Access | Times Cited: 30
Adina F. Turcu, Winnie Nhan, Seda Grigoryan, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 14
Open Access | Times Cited: 30
Prevalence of Functioning Adrenal Incidentalomas: A Systematic Review and Meta-analysis
Elisa Sconfienza, Martina Tetti, Vittorio Forestiero, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 7, pp. 1813-1823
Closed Access | Times Cited: 22
Elisa Sconfienza, Martina Tetti, Vittorio Forestiero, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 7, pp. 1813-1823
Closed Access | Times Cited: 22
Performance of Aldosterone-to-renin Ratio Before Washout of Antihypertensive Drugs in Screening of Primary Aldosteronism
X. Liu, Sufang Hao, Jin‐Song Bian, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2302-e2308
Open Access | Times Cited: 7
X. Liu, Sufang Hao, Jin‐Song Bian, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2302-e2308
Open Access | Times Cited: 7